Fny Investment Advisers, LLC Allakos Inc. Transaction History
Fny Investment Advisers, LLC
- $164 Million
- Q1 2025
A detailed history of Fny Investment Advisers, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 175,000 shares of ALLK stock, worth $57,750. This represents 0.02% of its overall portfolio holdings.
Number of Shares
175,000Holding current value
$57,750% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ALLK
# of Institutions
81Shares Held
69.2MCall Options Held
20.9KPut Options Held
0-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.88 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.2 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.19 Million0.01% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...